UGC CARE norms ugc approved journal norms IJRTI Research Journal

WhatsApp
Click Here

International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 8

Issue Published : 85

Article Submitted : 7838

Article Published : 4010

Total Authors : 10466

Total Reviewer : 547

Total Countries : 81

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: An Insight To Intravenous Drug Incompatibilities For Better Patient Care
Authors Name: Dr. P. Malarvizhi , Anusree , Archana K S , Aswini S Binu
Download E-Certificate: Download
Author Reg. ID:
IJRTI_184390
Published Paper Id: IJRTI2210064
Published In: Volume 7 Issue 10, October-2022
DOI:
Abstract: This article aims to improve the knowledge of incompatibilities and compatibilities among intravenous drugs to improve the quality of life, reduce drug interactions, complications, minimizing therapeutic error due to incompatibility among intravenous drugs. Providing an insight to health-care professionals regarding appropriate usage of intravenous drugs concomitantly, creating awareness and justifying the role of clinical pharmacist. Since, critical care settings are more prone to complications due to incompatibilities among intravenous therapy, this approach may prove to be helpful for understanding the need to minimize undesirable effects and promote patient safety.
Keywords: Incompatibility, Intravenous, Clinical pharmacist, Undesirable effects
Cite Article: "An Insight To Intravenous Drug Incompatibilities For Better Patient Care", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.7, Issue 10, page no.489 - 491, October-2022, Available :http://www.ijrti.org/papers/IJRTI2210064.pdf
Downloads: 000202418
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2210064
Registration ID:184390
Published In: Volume 7 Issue 10, October-2022
DOI (Digital Object Identifier):
Page No: 489 - 491
Country: Namakkal, Tamil Nadu, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2210064
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2210064
Share Article:

Share Facebook Twitter Google+ Pinterest LinkedIn Email Tumblr WhatsApp Google Gmail

Click Here to Download This Article

Article Preview
Click Here to Download This Article
Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Join RMS/Earn 300
IJRTI

Indexing Partner
Copyright © 2023 - All Rights Reserved - IJRTI